Category: Novartis

Faculty Positions in Biological Sciences, Immunology job with XIAN JIAOTONG LIVERPOOL UNIVERSITY (XJTLU)

School: School of Science Department: Biological Sciences Position: Faculty Positions in Biological Sciences_Immunology Location: Suzhou, China Contract Type: Fixed-term, renewable. 3rd contract is open-ended ABOUT XJTLU In 2006 Xi’an Jiaotong-Liverpool University (XJTLU) was created by the University of Liverpool and Xi’an Jiaotong University – a top ten university in China….

Continue Reading Faculty Positions in Biological Sciences, Immunology job with XIAN JIAOTONG LIVERPOOL UNIVERSITY (XJTLU)

The Accept Phase Ib/II Single Arm Study

Oral and Poster Abstracts 626. Aggressive Lymphomas: Prospective Therapeutic Trials: Poster III Research, clinical trials, Lymphomas, Clinical Research, Combination therapy, Diseases, aggressive lymphoma, Therapies, Lymphoid Malignancies Andrew J Davies, BSc, BM, FRCP, PhD1,2*, Josh Caddy, BSc3*, Katy McLaughlin, BSc3*, Christopher Wignall, MSc3*, Robert…

Continue Reading The Accept Phase Ib/II Single Arm Study

Sickle Cell Disease Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

Sickle Cell Disease pipeline constitutes 40+ key companies continuously working towards developing 50+ Sickle Cell Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Sickle Cell Disease Overview Sickle Cell Disease is a group of inherited red blood cell disorders that…

Continue Reading Sickle Cell Disease Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

B.Tech Bioinformatics Jobs, Scope, Salary in India 2022

B.Tech Bioinformatics is a course that gives the students a variety of job roles. The private and public sectors are demanding for B.Tech Bioinformatics Graduates. Some of the job roles of B.Tech Bioinformatics Graduates include; Research Scientists, Bioinformatics software developers, Bioinformaticians, Laboratory Assistants, Teaching Assistants, Clinical Research coordinators, Bioinformatics Analyst,…

Continue Reading B.Tech Bioinformatics Jobs, Scope, Salary in India 2022

Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders

— Founded on the first and only platform designed to genetically engineer small molecule therapeutics from fungi and plants — — Led by veteran biotech executives Usman Azam, Chief Executive Officer, and Fred Grossman, Chief Medical Officer — NEW YORK & CAMBRIDGE, England, October 18, 2022–(BUSINESS WIRE)–Empyrean Neuroscience, Inc., a…

Continue Reading Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders

Global Fibroblast Growth Factor Receptor 2 market key industry players and their market scope 2022

Pune, Maharashtra, India, September 22 2022 (Wiredrelease) Marke.biz–:The research provides the Global Fibroblast Growth Factor Receptor 2 Market aims at leveraging the insights and perspectives derived based on both qualitative and quantitative data evaluations for the forecast period, 2022-2030. The use of the technology for malady wipeout through direct correction of disturbances…

Continue Reading Global Fibroblast Growth Factor Receptor 2 market key industry players and their market scope 2022

The Global CRISPR Market Evaluated to Surge at $4521.76 Million

CRISPR Market A recent study by Triton Market Research titled ‘Global CRISPR Market’ includes the Global Analysis and Forecasts by Industry Verticals (Therapeutics and Drug Discovery, Biological Research, Agricultural Biotech, Industrial Biotech), Application (Genome Editing/Genetic Engineering, Cell Line Engineering, CRISPR Plasmid, Human Stem Cells, gRNA Database/Gene Library), Product (Designing Tools,…

Continue Reading The Global CRISPR Market Evaluated to Surge at $4521.76 Million

Global Gene Therapy R&D Market Worth US$ 22,685.70 million by 2031: Visiongain Reports Ltd

Visiongain Reports Ltd Global Gene Therapy R&D Market Forecast 2021-2031: – Market Segment by Disease {Cancer, Rare Diseases (Oncologic, Non-Oncologic), Cardiovascular Diseases, Ophthalmic Diseases, Hematology, Neurological, Diabetes Mellitus, Other Diseases}, Vector {Viral (Retrovirus, Adenovirus, AAV, Lentivirus, Others), Non-Viral (Naked DNA, Gene Gun, Electroporation, Lipofection)}, Techniques (Gene Augmentation Therapy, Gene Replacement…

Continue Reading Global Gene Therapy R&D Market Worth US$ 22,685.70 million by 2031: Visiongain Reports Ltd

Injectable Drugs Market Analysis of the Competitive Landscape, with a Forecast for 2027

Wilmington, Delaware, United States, Transparency Market Research Inc. – The global injectable drugs market is relied upon to enlist a strong double-digit CAGR within the forecast period from 2019 to 2027. The market is majorly classified on the basis of drug-class, geography, molecule-type, and application. From the previous one entire…

Continue Reading Injectable Drugs Market Analysis of the Competitive Landscape, with a Forecast for 2027

DeepMind has predicted the shape of every protein known to science. How excited should we be?

It doesn’t have much photogenic appeal or the glamour of seeing back in time, but a new development in computational biochemistry has been hailed as a discovery as important as the images of distant galaxies recently seen through the James Webb Space Telescope. Researchers at DeepMind—the AI company owned by…

Continue Reading DeepMind has predicted the shape of every protein known to science. How excited should we be?

Intellia: Slim Hopes Of Near-Term Commercial Revenue, Bearish

liulolo/iStock via Getty Images Investment Thesis If you had invested in the CRISPR / Cas9 gene editing pioneer Intellia Therapeutics (NASDAQ:NTLA) five years ago, you would likely be well satisfied with your return to date – a ~285% return on your investment – although you may also feel that it…

Continue Reading Intellia: Slim Hopes Of Near-Term Commercial Revenue, Bearish

Novartis announces promising five-year data for leukaemia treatment Kymriah

Novartis has shared long-term, five-year follow-up results from its pivotal clinical phase 2 trial, ELIANA, evaluating Kymriah (tisagenlecleucel), the first-ever approved CAR T-cell therapy, in children and young adult patients with relapsed or refractory (r/r) B-cell acute lymphoblastic leukaemia (ALL). Kymriah is a one-off treatment designed to help patients’ immune…

Continue Reading Novartis announces promising five-year data for leukaemia treatment Kymriah

Global DNA Nanotechnology Market Report 2022-2027 Featuring Major Players

DUBLIN, May 20, 2022 /PRNewswire/ — The “Global DNA Nanotechnology Market, By Type, By Application, By End User, By Region, Competition Forecast and Opportunities, 2017-2027” report has been added to ResearchAndMarkets.com‘s offering. Global DNA nanotechnology market is projected to register growth at a significant rate during the forecast period, 2023-2027 with…

Continue Reading Global DNA Nanotechnology Market Report 2022-2027 Featuring Major Players